Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health

by Nicolette Stogios, Alexander Gdanski, Philip Gerretsen, Araba F. Chintoh, Ariel Graff-Guerrero, Tarek K. Rajji, Gary Remington, Margaret K. Hahn, Sri Mahavir Agarwal
Published 2021-04-01

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia

by Nicole E. MacKenzie, Chantel Kowalchuk, Chantel Kowalchuk, Sri Mahavir Agarwal, Sri Mahavir Agarwal, Kenya A. Costa-Dookhan, Kenya A. Costa-Dookhan, Fernando Caravaggio, Fernando Caravaggio, Philip Gerretsen, Philip Gerretsen, Philip Gerretsen, Araba Chintoh, Araba Chintoh, Gary J. Remington, Gary J. Remington, Gary J. Remington, Valerie H. Taylor, Valerie H. Taylor, Daniel J. Müeller, Daniel J. Müeller, Daniel J. Müeller, Ariel Graff-Guerrero, Ariel Graff-Guerrero, Ariel Graff-Guerrero, Margaret K. Hahn, Margaret K. Hahn, Margaret K. Hahn
Published 2018-12-01

The effect of ethnicity and immigration on treatment resistance in schizophrenia

by Ali Bani-Fatemi, Samia Tasmim, Ariel Graff, Philip Gerretsen, Oluwagbenga O. Dada, James L. Kennedy, Nuwan Hettige, Clement Zai, Danilo de Jesus, Andrea de Bartolomeis, Vincenzo De Luca
Published 2019-02-01

Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophrenia

by Takashi Itahashi, Yoshihiro Noda, Yusuke Iwata, Ryosuke Tarumi, Sakiko Tsugawa, Eric Plitman, Shiori Honda, Fernando Caravaggio, Julia Kim, Karin Matsushita, Philip Gerretsen, Hiroyuki Uchida, Gary Remington, Masaru Mimura, Yuta Y. Aoki, Ariel Graff-Guerrero, Shinichiro Nakajima
Published 2021-01-01